Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects



Rating:

Share or cite this content

Citations should be made in the following way:
K. Zayen (Ariana, Tunisia), H. Snène (Ariana, Tunisia), H. Blibech (Ariana, Tunisia), W. Fenina (Ariana, Tunisia), I. El Wadhane (Ariana, Tunisia), M. Maalej (Ariana, Tunisia), A. Jebali (Ariana, Tunisia), J. Daghfous (Ariana, Tunisia), N. Mehiri (Ariana, Tunisia), N. Ben Salah (Ariana, Tunisia), B. Louzir (Ariana, Tunisia). Asthma management and control during COVID-19 pandemic. 970

Member's Comments

No comment yet.

Related content which might interest you: Impact of COVID-19 on COPD and Asthma admissions and the pandemic from a patient’s perspective Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Asthma control in a national asthma program Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Guideline adherence in the management of pandemic flu: From panic to pragmatic Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 Asthma control: evidence-based monitoring and the prevention of exacerbations Source: Breathe 2008; 4: 310-319 Year: 2008 Interim analysis of post-marketing surveillance of omalizumab in Japan Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Management of respiratory diseases in the COVID-19 pandemic Source: COVID-19 Videos Year: 2020 Costs of managing asthma as defined by a derived Asthma Control TestTM score in seven European countries Source: Eur Respir Rev 2006; 15: 17-23 Year: 2006 The British Lung Foundation asthma management programme - improving asthma control in adults Source: International Congress 2017 – Improve your competences: new directions from medical education Year: 2017 Prevalence of respiratory virus in a selected population of children with asthma exacerbation Source: Annual Congress 2013 –Preschool wheeze Year: 2013 Introduction of new asthma guidelines did not improve asthma control in a Dutch paediatric population Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Asthma control in the workplace Source: Eur Respir J 2014; 43: 319-321 Year: 2013 Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Asthma management in a specialist setting: Results of a national survey Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Asthma management and prevention in childhood-our experience Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001 Differences in asthma control and management in Europe Source: Annual Congress 2013 –The kaleidoscope of respiratory nursing Year: 2013 The British Lung Foundation asthma management programme - improving children's asthma control Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Cough monitoring during the covid-19 pandemic Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Factors influencing on influenza vaccination among chronic obstructive pulmonary disease: The Korea national health and nutrition examination survey Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Influenza vaccination in chronic asthma patients. Are more severely ill patients more likely to seek vaccination? Source: Annual Congress 2013 –Viral infections Year: 2013